Bronchial asthma in children is a chronic inflammatory disease of the respiratory system due to a hyper-responsive state of the bronchial airways caused by various reasons. It can have a very significant impact on a child’s body, and prolonged treatment may lead to malnutrition and developmental delays. The treatment of asthma in children needs to adhere to the principles of long-term, standardized, continuous and individualized. Asthma attacks in children should quickly relieve symptoms, including wheezing, shortness of breath, dyspnea and so on. Anti-inflammatory treatment can reduce the congestion and edema of the airways. Antibiotics can be used if accompanied by bacterial infection. Glucocorticosteroids and bronchodilator drugs can be used to relieve bronchial smooth muscle spasm and relieve wheezing. The severity of asthma symptoms in children with acute exacerbations can be categorized as mild, moderate, severe, or very severe. Glucocorticoids are the most effective anti-inflammatory drugs for acute asthma attacks. They usually usually require a week of continuous regular use to be effective. That is why glucocorticoids are often combined with bronchodilators such as terbutaline, salbutamol, etc. or aminophyllines. Moderate to more severe asthma requires long-term inhaled glucocorticosteroids such as Pulmicort aerosol. Succinylated cortisone, methylprednisolone, or dexamethasone should be given early in a severe asthma attack through an intravenous drip. However, this does not usually work until six hours after the intravenous injection, so the medication should be given as soon as possible and along with a bronchodilator, usually for one to seven days. In the remission phase of bronchial asthma, prophylactic glucocorticosteroids and leukotriene inhibitors such as montelukast and h1-receptor antagonists such as ketotifen should be used. Chinese medicines such as Yubingfeng granules can also be taken for a period of time. Follow up regularly to adjust the treatment program.